Advertisement

Related Videos

Leonard B. Saltz, MD, on the Future of Interventional Pharmacoeconomics

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

Peter Clark, MA, MD, FRCP: A Payer Perspective

Varsha Gandhi, PhD, on Ibrutinib

CS Pramesh, MS, FRCS, on Opportunities in India: A Perspective From a Low-Middle Income Country

Advertisement

Advertisement




Apr
28
Today In Oncology
RAS Inhibitor Daraxonrasib in Metastatic Pancreatic Cancer
Early-Onset Lung Cancer May Be Connected to Pesticide Contaminants
ACP Issues Controversial New Breast Cancer Screening Guidelines
Educational Disparities in Young-Onset Colorectal Cancer Mortality
Breast Cancer Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxicity
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo